Fusion Pharmaceuticals Inc Revenue per Employee (FUSN), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Fusion Pharmaceuticals Inc   (NASDAQ: FUSN)
 

Fusion Pharmaceuticals Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Fusion Pharmaceuticals Inc 's Revenue per employee fell on a trailing twelve month basis to $ 75,556, but the productivity of Fusion Pharmaceuticals Inc 's employees remained above the company average.
Within the Healthcare sector Fusion Pharmaceuticals Inc achieved the highest revenue per employee. While revenue/employee total ranking has improved so far to , from total ranking in previous quarter at 4219. Fusion Pharmaceuticals Inc has 27 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

FUSN Revenue per Employee (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter
Y / Y Revenue Change - -100 % 1108.43 % -94.04 % -95.21 %
Sales per Employee (TTM) $ 75,556 76,593 81,778 13,630 33,481
FUSN's Total Ranking # # 4219 # 3783 # 4093 # 4063
Seq. Revenue Change - -100 % 5800 % 21.43 % -80 %

FUSN Company Profile >> Back to FUSN Efficiency Comparisons >> Compare FUSN Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall Market #

Revenue per Employee Statistics
High Average Low
$ 81,778 $ 60,292 $ 13,630
(Sep 30 2023)   (Jun 30 2023)



Financial Statements
Fusion Pharmaceuticals Inc 's Revenue MRQ $ 0 Millions Visit FUSN's Income Statement
Fusion Pharmaceuticals Inc 's Revenues TTM $ 2 Millions Visit FUSN's aggregate revenue growth
What are FUSN's Sales? Visit FUSN's Sales by Segment




Other Ratios
Fusion Pharmaceuticals Inc 's Income per Employee
Employees in Biotechnology & Pharmaceuticals
Biotechnology & Pharmaceuticals Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
FUSN's Revenue per Employee versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for FUSN's Competitors
Revenue per Employee for FUSN's Suppliers
Revenue per Employee for FUSN's Customers

You may also want to know
FUSN's Sales Growth Rates FUSN's Pe Price to earnings ratio FUSN's Receivables Turnover Ratio FUSN's Stock Quote
FUSN's Net Income Growth Rates FUSN's Ps Price to Sales ratio FUSN's Sales per Employee FUSN's Asset Turnover Ratio
FUSN's Net Margin FUSN's Pb Price to Book ratio FUSN's Financial Strength Ratios FUSN's Dividend Payout Ratio
Date modified: 2026-09-08T15:22:13+00:00




Companies with similar Revenue per Employee for 12 months ending Mar 31 2024, within Healthcare Sector Revenue per Employee Revenue 12 months ending Mar 31 2024Number of Employees Mar 31 2024
Seelos Therapeutics inc   132,187.50 $ 2.115  Million 16 
Sangamo Therapeutics Inc   132,084.51 $ 18.756  Million 142 
Qhslab Inc   128,731.92 $ 1.545  Million 12 
Sharecare Inc   125,243.74 $ 419.817  Million 3,352 
Tenon Medical Inc   123,615.38 $ 3.214  Million 26 
T2 Biosystems Inc   119,600.00 $ 7.176  Million 60 
Amedisys Inc  118,495.11 $ 2,251.407  Million 19,000 
Acadia Healthcare Company Inc   118,443.96 $ 2,961.099  Million 25,000 
Encompass Health Corporation  118,019.05 $ 4,956.800  Million 42,000 
Cardiff Oncology Inc   117,967.74 $ 3.657  Million 31 
Capricor Therapeutics inc   117,308.43 $ 27.098  Million 231 
Verrica Pharmaceuticals Inc   117,276.32 $ 8.913  Million 76 
Ontrak Inc   114,913.46 $ 11.951  Million 104 
60 Degrees Pharmaceuticals Inc   114,044.00 $ 0.342  Million 3 
Dariohealth Corp   111,212.12 $ 18.350  Million 165 
Neuronetics Inc   109,806.99 $ 72.253  Million 658 
Encision Inc   109,764.70 $ 6.586  Million 60 
Biomerica Inc   108,104.16 $ 5.405  Million 50 
Innovative Eyewear Inc   107,002.23 $ 1.391  Million 13 
Pressure Biosciences Inc   105,760.73 $ 1.586  Million 15 
4d Molecular Therapeutics Inc   104,352.04 $ 20.453  Million 196 
Tscan Therapeutics Inc   104,309.86 $ 14.812  Million 142 
Hcw Biologics Inc   104,148.26 $ 3.645  Million 35 
Lineage Cell Therapeutics Inc   103,935.06 $ 8.003  Million 77 
Kronos Bio Inc   102,527.03 $ 7.587  Million 74 
Solventum Corporation  100,800.00 $ 2,016.000  Million 20,000 
Lifestance Health Group Inc   100,676.31 $ 1,103.513  Million 10,961 
Adm Tronics Unlimited Inc   98,846.87 $ 2.965  Million 30 
Provectus Biopharmaceuticals Inc   98,459.50 $ 0.591  Million 6 
Renalytix Plc  98,192.31 $ 5.106  Million 52 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.